Vladimir Anikin Thoracic Surgeon Profile at Royal Brompton: Specialisms and Patient Outcomes

Professor Vladimir Anikin has built a distinguished career at the intersection of thoracic oncology, minimally invasive surgery, and complex reconstructive procedures. With nearly five decades of clinical experience spanning Russia, Northern Ireland, Yorkshire, and ultimately London, he represents a rare depth of expertise within the United Kingdom's thoracic surgical community. Patients and referring clinicians seeking out the RBHT Vladimir Anikin thoracic surgeon profile will find a practitioner whose training trajectory is as unconventional as it is impressive, beginning with specialist oncology preparation in Moscow and culminating in a senior consultancy at one of the world's most respected cardiothoracic centres.

For anyone navigating a serious thoracic diagnosis, understanding who is treating you and why matters enormously. This review examines Professor Anikin's clinical specialisms, his technical approach, the technology he employs, and the honest trade-offs patients and referring doctors should weigh when considering his care. It draws on publicly available professional profiles, institutional listings, and the broader context of thoracic surgical practice in the UK to give a clear and balanced picture.

Other Doctors to Consider

Exploring Your Options Beyond the Hospital Setting

Royal Brompton and Harefield NHS Foundation Trust is a world-class institution, but it is not always the only path forward, and for many patients, seeking a second opinion or exploring independent consultants unlocks faster access and a more personalised experience.

Consultant thoracic surgeons in private practice can often offer same-week consultations, direct booking without a GP referral, and a continuity of care that a large NHS environment does not always make easy.

Mr Marco Scarci is a name that consistently surfaces for patients considering thoracic surgery in London. A consultant thoracic surgeon with over 20 years of experience and more than 5,000 minimally invasive procedures completed, he offers direct access to lung cancer surgery, VATS-based procedures, and chest wall treatments, with hospital stays averaging 25% shorter than the national benchmark. For patients who want to move quickly from diagnosis to treatment, or who are weighing a second opinion before committing to a surgical plan, Mr Scarci's practice provides a well-regarded, accessible route into high-quality thoracic care.

Professor Vladimir Anikin's Background and Training

A Career Built Across Two Continents

Professor Anikin's formation as a surgeon is genuinely unusual by contemporary UK standards. He received his thoracic surgical oncology training at the PA Hertzen Cancer Research Institute in Moscow during the early 1980s, where he developed a thesis on multiple primary tumours of the lung, a subject he later published as a standalone book. That grounding in oncology research gave him a scientific rigour that has underpinned his clinical practice ever since.

Following his early career in northern Russia, where he worked as both a thoracic and general surgeon, he joined the Medical Radiological Research Institute of the Russian Academy of Medical Sciences as a senior researcher, focusing on oesophageal surgery. His move to the United Kingdom in the early 1990s brought him first to the Royal Victoria Hospital in Belfast, then to Bradford Royal Infirmary as a consultant in 2000, and subsequently to Leeds General Infirmary, before he was appointed consultant thoracic surgeon at Harefield Hospital in 2007.

His qualifications include the FRCS(Ed-Ctx) fellowship, and he operates with fluency in both English and Russian, which broadens his accessibility to a diverse patient population in and around London.

Core Clinical Specialisms

What Professor Anikin Treats and How

Professor Anikin's clinical scope covers general thoracic surgical procedures, with the explicit exclusion of transplantation, a standard boundary for most non-transplant thoracic centres. His listed areas of expertise include lung cancer, oesophageal cancer, tracheal stenosis, and thoracoscopy and video-assisted thoracic surgery (VATS). He also performs diagnostic and interventional endoscopy, giving him coverage across both the surgical and endoscopic ends of thoracic care.

Among his more distinctive contributions is his work with locally advanced chest tumours, reconstructive lung surgery, and complex endobronchial interventions. His profile at Guy's and St Thomas' Specialist Care further notes expertise in reconstructive chest wall surgery following previous interventions for congenital and cardiac pathology, a niche area that requires both technical precision and a thorough understanding of prior surgical anatomy.

Pioneering Technologies in His Practice

PlasmaJet, Cryosurgery, and 3D VATS

One of the most compelling aspects of Professor Anikin's practice is his adoption of technologies that remain uncommon even within specialist centres. He uses PlasmaJet technology for pleural pathology, malignant mesothelioma, and metastatic lung tumours, a tool that expands surgical options for patients who might otherwise face limited treatment routes. The technique allows for targeted tissue destruction with a degree of precision that conventional methods cannot easily replicate.

He is also among a small cohort of UK thoracic surgeons using cryosurgery to treat endobronchial tumours. This approach, documented through a link on the RBHT website itself, is particularly valuable for improving quality of life and prolonging survival in patients with advanced lung cancer, as well as for managing other endobronchial tumours where major resection surgery would carry unacceptable risk. His use of 3D video-assisted thoracic surgery adds a further layer of technical capability, enabling greater depth perception during minimally invasive procedures.

These technologies collectively reflect a practice that is oriented toward expanding the reach of treatment, particularly for patients with complex, advanced, or previously inoperable disease.

Research Profile and Academic Contributions

A Surgeon Who Also Advances the Field

Professor Anikin's academic output is substantial and measurable. His ResearchGate profile lists 79 publications with over 1,000 citations, a figure that places him well within the upper tier of clinician-researchers in thoracic surgery globally. His work spans case series on pulmonary metastases from rare cancers such as uveal melanoma, procedural techniques, and outcomes data that feed directly into clinical decision-making across the specialty.

This research output is not merely a professional credential. It signals a surgeon who is continuously interrogating outcomes, contributing to the evidence base, and operating in dialogue with the wider scientific community. For patients with rare or complex presentations, a surgeon who is also an active researcher in their condition is a meaningful advantage.

His published book on multiple primary tumours of the lung remains a reference point in thoracic oncology, and his earlier work at the Russian Academy of Medical Sciences has given him a perspective on oesophageal and pulmonary disease that spans decades and multiple healthcare systems.

Potential Limitations and Practical Considerations

What Patients Should Weigh Carefully

No professional profile review would be complete without an honest account of the practical limitations that attend care in a large NHS foundation trust. Professor Anikin does not appear to be actively collecting patient reviews on platforms such as Doctify, meaning there is currently no accessible repository of verified patient feedback to draw on when assessing bedside manner, communication clarity, or post-operative support quality. This is not unusual among senior NHS consultants, but it does leave a gap that privately practising surgeons, who typically build and maintain public review profiles, do not have.

Waiting times at Royal Brompton and Harefield NHS Foundation Trust, as with any major NHS centre, can be variable depending on urgency classification, referral pathway, and current capacity pressures. Patients who require swift access to surgical consultation or who prefer to self-refer may find the NHS pathway slower than they would like. Access to Professor Anikin specifically, given his seniority and specialist remit, is likely routed through formal consultant-to-consultant referral in most cases.

Additionally, while his range of specialisms is broad, the exclusion of transplantation from his listed procedures is worth noting for any patient who may be heading toward end-stage lung disease management, where transplantation could eventually become relevant.

Oesophageal Surgery Expertise

An Often-Overlooked Dimension of His Practice

While Professor Anikin is most prominently associated with thoracic and lung surgery, his oesophageal surgery expertise deserves separate attention. His formative years as a senior researcher at the Medical Radiological Research Institute were centred specifically on oesophageal disease, and this strand of his practice has continued throughout his UK career. Oesophageal cancer is among the most technically demanding of all gastrointestinal malignancies, requiring surgical access through the chest and abdomen, often with significant post-operative rehabilitation requirements.

For patients presenting with oesophageal cancer or complex benign oesophageal conditions, Professor Anikin's dual competency in both thoracic and oesophageal surgery is clinically significant. It means that a surgeon managing a lung cancer case can also bring informed judgement to cases where disease overlaps anatomical boundaries, a scenario more common in advanced or recurrent malignancy than is often appreciated.

Evaluating the Overall Patient Profile

Who Benefits Most From His Care

Based on the totality of his published expertise and professional record, Professor Anikin is likely best suited to patients with complex, advanced, or rare thoracic conditions who require a surgeon with a genuine research and technological background. His use of PlasmaJet and cryosurgery, in particular, positions him as a resource for cases where standard resection is not the appropriate first option, either because of disease extent, patient fitness, or the endobronchial nature of the tumour.

Patients with locally advanced chest tumours, malignant mesothelioma, metastatic pulmonary disease, tracheal stenosis, or complex chest wall reconstruction needs will find in his profile a level of subspecialist depth that is not widely available. Similarly, patients with multiple primary lung tumours, a subject on which he literally wrote the book, may benefit from his specific expertise in ways that a more generalist thoracic surgeon could not replicate.

Where his profile is less compelling is for patients who prioritise continuity through easily accessible patient reviews, rapid self-referral pathways, or confirmed data on average procedure turnaround times. For those patients, an independent consultant in the private sector may offer a more frictionless experience, even if the underlying surgical calibre is comparable.

Final Thoughts on a Consequential Choice

Choosing a thoracic surgeon is one of the most significant decisions a patient or their clinical team will make, and Professor Vladimir Anikin's profile at Royal Brompton and Harefield NHS Foundation Trust deserves to be understood with precision rather than generalisation. His career combines genuine oncology depth, a strong academic record, and a commitment to technologies that extend the reach of surgical care for patients who would otherwise have fewer options. Those strengths are real, and for the right patient, they are decisive.

The honest caveat is that his suitability depends significantly on the nature of the presenting condition and the patient's priorities. For complex, advanced, or technically demanding cases arriving through formal NHS referral channels, his expertise is among the strongest available in the United Kingdom. For patients navigating more straightforward presentations or seeking faster private access, the landscape of thoracic surgery in London offers excellent alternatives worth exploring in parallel.